相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pembrolizumab Plus Chemotherapy in Advanced Endometrial Cancer
Ramez N. Eskander et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2023)
Endometrial Cancer: Who Lives, Who Dies, Can We Improve Their Story?
Casey M. Cosgrove et al.
ONCOLOGIST (2021)
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Molecularly Classified Endometrial Carcinoma
Mikko Loukovaara et al.
CANCERS (2021)
Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer
A. Guyot D'Asnieres De Salins et al.
ESMO OPEN (2021)
MSH6 immunohistochemical heterogeneity in colorectal cancer: comparative sequencing from different tumor areas
Wei Chen et al.
HUMAN PATHOLOGY (2020)
Reliable Clinical MLH1 Promoter Hypermethylation Assessment Using a High-Throughput Genome-Wide Methylation Array Platform
Jamal K. Benhamida et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas
Alicia Leon-Castillo et al.
JOURNAL OF PATHOLOGY (2020)
Interpretation of somatic POLE mutations in endometrial carcinoma
Alicia Leon-Castillo et al.
JOURNAL OF PATHOLOGY (2020)
Size matters: Dissecting key parameters for panel-based tumor mutational burden analysis
Ivo Buchhalter et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker
Floor J. Backes et al.
CANCER (2019)
DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression
Satu Maki-Nevala et al.
EBIOMEDICINE (2019)
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
S. Kommoss et al.
ANNALS OF ONCOLOGY (2018)
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer
Casey M. Cosgrove et al.
GYNECOLOGIC ONCOLOGY (2018)
Endometrial cancer risk and survival by tumor MMR status
Christina M. Nagle et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2018)
Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer
Rajmohan Murali et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition
David A. Fabrizio et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Practical guidance for mismatch repair-deficiency testing in endometrial cancer
E. Stelloo et al.
ANNALS OF ONCOLOGY (2017)
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival
Casey M. Cosgrove et al.
GYNECOLOGIC ONCOLOGY (2017)
Differences in Microsatellite Instability Profiles between Endometrioid and Colorectal Cancers A Potential Cause for False-Negative Results?
Yang Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Confirmation of ProMisE: A Simple, Genomics-Based Clinical Classifier for Endometrial Cancer
Aline Talhouk et al.
CANCER (2017)
Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas
M. K. McConechy et al.
GYNECOLOGIC ONCOLOGY (2015)
Polymerase ε (POLE) Mutations in Endometrial Cancer: Clinical Outcomes and Implications for Lynch Syndrome Testing
Caroline C. Billingsley et al.
CANCER (2015)
POLE Mutations as an Alternative Pathway for Microsatellite Instability in Endometrial Cancer: Implications for Lynch Syndrome Testing
Panagiotis A. Konstantinopoulos et al.
CANCER (2015)
Performance Characteristics of Screening Strategies for Lynch Syndrome in Unselected Women With Newly Diagnosed Endometrial Cancer Who Have Undergone Universal Germline Mutation Testing
Sarah E. Ferguson et al.
CANCER (2014)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Prevalence of Lynch Syndrome among Patients with Newly Diagnosed Endometrial Cancers
Cecilia Egoavil et al.
PLOS ONE (2013)
Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome - Part II. The utility of microsatellite instability testing
Liying Zhang
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome - Part I. The utility of immunohistochemistry
Jinru Shia
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Heterogeneous staining for mismatch repair proteins during population-based prescreening for hereditary nonpolyposis colorectal cancer
Natasha Watson et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer
V Piñol et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history
BM Buttin et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers
PJ Goodfellow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
